← Open Payments lookup

KATHERINE SPRINGMAN: Open Payments

NPI 1992162457 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$783 in 34 payments from 15 companies in 2025. Trend: 2023 $395 · 2024 $272 · 2025 $783

Food & beverage: $684Education: $99
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation9$179
Aveo Pharmaceuticals, Inc.1$99
Daiichi Sankyo Inc.4$84
ABBVIE INC.3$74
AstraZeneca Pharmaceuticals LP3$62
PFIZER INC.3$54
Genmab U.S., Inc.2$47
GENZYME CORPORATION2$45
Secura Bio, Inc.1$26
PUMA BIOTECHNOLOGY, INC.1$21

Products named: FOTIVDA, KISQALI, Enhertu, Tivdak, LUTATHERA, DATROWAY, VENCLEXTA, PLUVICTO.

Industry payments across IN — which companies pay providers there.